Starling Oncology Institute, Inc. Common Stock
STLN
31 hedge funds and large institutions have $4.61M invested in Starling Oncology Institute, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 8 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
7.8% less ownership
Funds ownership: 27.27% → 19.47% (-7.8%)
9% less funds holding
Funds holding: 34 → 31 (-3)
34% less capital invested
Capital invested by funds: $6.98M → $4.61M (-$2.37M)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FL
FreeGulliver LLC
New Orleans,
Louisiana
|
+$107K |
| 2 |
TAS
TIFF Advisory Services
Radnor,
Pennsylvania
|
+$89.8K |
| 3 |
VF
Virtu Financial
New York
|
+$34.2K |
| 4 |
Jane Street
New York
|
+$28.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$16.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.55M |
| 2 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
-$654K |
| 3 |
BFM
Boston Financial Management
Boston,
Massachusetts
|
-$253K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$29.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ANTB
26
AMG National Trust Bank
Greenwood Village,
Colorado
| $3.09K | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $902 | +$55 | +211 | +8% |
|
28
Citigroup
New York
| $196 | +$158 | +609 | +2,436% |
|
29
JP Morgan Chase
New York
| $51 | -$1 | -5 | -3% |
|
30
BNP Paribas Financial Markets
Paris,
France
| $2 | +$1 | +5 | New |
|
|
31
Fidelity Investments
Boston,
Massachusetts
| – | -$1.55M | -4,749,900 | Closed |
|
|
KLP
32
Kent Lake PR
Anasco,
Puerto Rico
| – | -$654K | -2,000,000 | Closed |
|
|
33
Citadel Advisors
Miami,
Florida
| – | -$29.9K | -91,337 | Closed |
|
|
34
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$11.2K | -34,411 | Closed |
|
|
CAM
35
Cresset Asset Management
Chicago,
Illinois
| – | -$5.98K | -18,300 | Closed |
|
|
TSS
36
Two Sigma Securities
New York
| – | -$5.56K | -16,997 | Closed |
|
37
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$5.11K | -15,642 | Closed |
|
|
BFM
38
Boston Financial Management
Boston,
Massachusetts
| – | -$253K | -2,679 | Closed |
|
|
CAL
39
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | +$316 | +1,219 | New |
|
STLN Hedge Fund Activity: Q4 2024 in Review
31 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Institute, Inc. Common Stock (STLN) for Q4 2024, worth a combined $4.61M — down 34% from $6.98M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of STLN and 5 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 9 added.
The largest buyer was FreeGulliver LLC, adding an estimated $107K. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.55M sold.
- 31 institutional investors held Starling Oncology Institute, Inc. Common Stock (STLN) as of Q4 2024, down from 34 in Q3 2024.
- Funds reported $4.61M of Starling Oncology Institute, Inc. Common Stock stock for Q4 2024, down 34% quarter-over-quarter.
- 5 funds opened new Starling Oncology Institute, Inc. Common Stock positions in Q4 2024 and 8 closed out, a net change of -3 holders.
- The largest Starling Oncology Institute, Inc. Common Stock buyer in Q4 2024 was FreeGulliver LLC, an estimated $107K added.
- The largest Starling Oncology Institute, Inc. Common Stock seller in Q4 2024 was Fidelity Investments, an estimated $1.55M sold.
Based on aggregated 13F filings for Q4 2024.